2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Vascular Solutions’ Gel-Block 10x Embolization Pledgets Cleared by FDA

November 25, 2014 -- Vascular Solutions, Inc. has received 510(k) clearance from the US Food and Drug Administration for its Gel-Block 10x embolization pledgets for use i…

FDA Clears Covidien’s Fortrex PTA Balloon to Facilitate AV Access for Hemodialysis

November 24, 2014 -- Covidien plc announced US Food and Drug Administration 510(k) clearance for its Fortrex over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) ba…

Bracco Diagnostics Launches Isovue Imaging Bulk Package for CT Suite

November 24, 2014 -- Bracco Diagnostics Inc., the United States subsidiary of Bracco Imaging SpA, announced the availability of its Isovue (iopamidol injection) imaging bulk p…

Endologix's Nellix Shows Very Low Endoleak Rate in EVAS FORWARD–Global Registry

November 20, 2014 -- Endologix, Inc. announced the presentation of initial clinical data from the company's EVAS FORWARD -- Global Registry, a postmarket study that prospe…

Two-Year PYTHAGORAS Data Presented for Lombard Medical’s Aorfix Device

November 20, 2014 -- Lombard Medical, Inc. announced the presentation of safety and efficacy data from the 2-year follow-up in the United States PYTHAGORAS premarketing approv…

Argon’s Cleaner XT and Cleaner 15 Rotational Thrombectomy Systems Cleared for Mechanical Declotting and Infusion in the Peripheral Vasculature

November 19, 2014 -- Argon Medical Devices, Inc. announced that the company has received clearance from the US Food and Drug Administration to begin marketing the Cleaner XT a…

Gore Announces 2014 Pioneers in Performance for North America

November 19, 2014 -- Gore & Associates announced the North American physicians being honored with the company’s 2014 Pioneers in Performance award. The biennial awar…

Click here for more News coverage

Current Supplement

Sponsored by CORDIS CORPORATION

New Standards in Angioplasty

Expert discussion and challenging case reviews show that we may be on the verge of a major transformation in angioplasty-centric therapy for lower extremity interventions.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $44.25  0.00%
AstraZeneca PLC $73.91  0.00%
Boston Scientific Corporation $12.81  0.00%
BTG plc $811.00  1.37%
Cardiovascular Systems Inc. $30.47  0.00%
Covidien plc $100.54  0.00%
CR Bard Inc. $167.17  0.00%
Edwards Lifesciences Corp. $129.16  0.00%
Endologix Inc. $12.95  0.00%
Hansen Medical, Inc. $0.87  0.00%
Vascular Market Price  Change
Johnson and Johnson $107.21  0.00%
Lombard Medical, Inc. $6.98  0.00%
Medtronic, Inc. $73.48  0.00%
Merit Medical Systems, Inc. $14.95  0.00%
St. Jude Medical Inc. $67.84  0.00%
The Medicines Company $26.54  0.00%
The Spectranetics Corporation $32.29  0.00%
TriVascular Technologies, Inc. $13.52  0.00%
Vascular Solutions Inc. $25.71  0.00%
Volcano Corporation $10.30  1.78%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media